Skip to content

Healthy Term Infants Fed Milk-Based Formulas

Healthy Term Infants Fed Milk-Based Formulas With A Supplemental Carotenoid

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02069522
Enrollment
91
Registered
2014-02-24
Start date
2014-02-28
Completion date
2015-02-28
Last updated
2015-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infants

Brief summary

This is a prospective, double blind, crossover study in healthy infants randomized to one of two study formulas. The trial will consist of two 21 day study feeding periods separated by a study washout period.

Interventions

OTHERStandard Milk-based Formula Containing Carotenoid

Fed ad libitum

OTHERInvestigational Milk-based Formula Containing Carotenoid

Fed ad libitum

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
14 Days to 28 Days
Healthy volunteers
Yes

Inclusion criteria

* Infant is in good health * Infant is a singleton from a full term birth with a gestational age of 37-42 weeks * Infant's birth weight was \> 2490 g (\ 5 lbs 8 oz) * Infant is between 14 and 28 days of age * Parent(s) confirm intention to feed their infant the study product(s) as the sole source of nutrition for the duration of the study * Parent(s) confirm intention not to administer vitamin or mineral supplements, DHA and ARA supplements, solid foods/juices to their infant from enrollment through the duration of the study

Exclusion criteria

* An adverse maternal, fetal or infant medical history that has potential for effects on tolerance, growth, and/or development. * Infants using medications (including OTC), home remedies, herbal preparations, probiotics or rehydration fluids that might affect gastrointestinal (GI) tolerance

Design outcomes

Primary

MeasureTime frameDescription
Carotenoid ConcentrationChange from Baseline to end of Study Period A (~21 Days)Plasma sample

Secondary

MeasureTime frameDescription
Carotenoid ConcentrationChange from Baseline to end Study Periods A (~21 Days) and B (~21 Days)Plasma sample

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026